There are 41 papers on pinch strength in aging research: 13 trials and 24 observational studies in people, 3 reviews.
See all 70 papers on pinch strength
“Pinch strength was moderately correlated with HGS (r = 0.46).”
- Human trial13
- Humans24
Interventions
1Multicomponent lifestyle program
upin humans1
1 study
Multicomponent lifestyle program
upin humans1
Multicomponent lifestyle program improves pinch strength in humans (relative to usual-routine control).
Human trialrelative to usual-routine control5 daysfemalesn = 62
Effects
3Mortality
no changein humans1
1 study
Mortality
no changein humans1
Pinch strength was not clearly linked with mortality in humans.
Humans2-yearn = 954
Frailty
mediatesin humans1
1 study
Frailty
mediatesin humans1
Pinch strength is linked with frailty in humans (log-OR = -0.07, 95% CI [-0.12, -0.03]).
Humansfemales
Cardiovascular disease
no changein humans1HR 0.9
1 study
Cardiovascular disease
no changein humans1HR 0.9
Pinch strength was not clearly linked with cardiovascular disease in humans (maintenance hemodialysis) (unadjusted HR 0.90, 95% CI 0.77-1.05).
Humansmaintenance hemodialysis24 monthsn = 140
Associations
6Falls
downin humans1OR 0.76
1 study
Falls
downin humans1OR 0.76
Pinch strength is linked with a lower risk of falls in humans (OR 0.76, 95% CI: 0.63-0.90).
Humans2-yearn = 954
Sarcopenia
upin humans1
1 study
Sarcopenia
upin humans1
Pinch strength predicts sarcopenia in humans (AUC 0.648 vs 0.694, P = .034).
Humansn = 954
Handgrip strength
upin humans1
1 study
Handgrip strength
upin humans1
Pinch strength is associated with handgrip strength in humans (r = 0.46).
Humansn = 954
Cognitive impairment
downin humans1OR 0.5
1 study
Cognitive impairment
downin humans1OR 0.5
Pinch strength is linked with a lower risk of cognitive impairment in humans (adjusted for age, sex, and education) (OR 0.50, 95 % CI 0.40-0.61).
Humansadjusted for age, sex, and educationn = 954
Mortality
downin humans1HR 0.78
1 study
Mortality
downin humans1HR 0.78
Pinch strength is linked with a lower risk of mortality in humans (maintenance hemodialysis) (HR 0.78, 95% CI 0.64-0.95).
Humansmaintenance hemodialysis24 monthsn = 140
Modified sphygmomanometer test
upin humans1
1 study
Modified sphygmomanometer test
upin humans1
Modified sphygmomanometer test is associated with pinch strength in humans (dominant side) (r = 0.44, p < 0.01).
Humansdominant siden = 50